BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Seegene and Werfen Join Forces to Develop Syndromic qPCR Assays Under OneSystem™

The collaboration will consist of the joint development of syndromic qPCR assays suitable for the Spanish and Portuguese healthcare systems, including assa...

June 15, 2023 | News

C2 PHARMA Receives Approval for Digoxin China DMF, Becoming China’s Only European Supplier of This API

C2 Pharma the global leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the appro...

June 14, 2023 | News

Translumina bolsters its German presence with acquisition of Lamed GmbH

Established in 1989, Lamed is a leading market access platform of vascular and cardiovascular products. It covers 1,000+ hospitals through its GPO network ...

June 07, 2023 | News

Olympus to Establish Digital Excellence Centers After Odin Vision Acquisition

Olympus, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, announced the plan to establish a series o...

June 06, 2023 | News

WuXi Biologics to Increase Manufacturing Capacity in Germany

- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...

June 02, 2023 | News

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 31, 2023 | News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo as neoadjuvant treatment for high-risk non-small cell lung cancer

If approved, Opdivo with chemotherapy would be the first and only neoadjuvant immunotherapy-based option authorized to treat patients with non-sm...

May 29, 2023 | Regulatory

Novo Nordisk and Life Edit Therapeutics collaborate on gene editing therapies for rare and cardiometabolic diseases

Life Edit has the option to a global profit share on one programme. Novo Nordisk will make an equity investment in ElevateBio, Li...

May 29, 2023 | News

Aptamer Group Consortium Wins Eurostars Grant for Prenatal Disease Diagnostic Device

As part of a consortium, Aptamer Group with it’s partners will develop a new medical device for improved non-invasive prenatal testing and the di...

May 23, 2023 | News

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...

May 23, 2023 | News

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix® Blood Test to Detect Prostate Cancer

Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced today that it entered into an agreement for Labcorp, a...

May 22, 2023 | News

Fertilix Successfully Blocks Low-Dose Chemical Damage in Plastic Consumer Products

The study, led by Professor Joel Drevet, examined two common chemicals widely used in the plastic industry: dibutyl phthalate and bisphenol AF. These chemi...

May 19, 2023 | News

GenNext® Technologies Partners with Emery Pharma for Biopharmaceutical Protein Footprinting

Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allos...

May 18, 2023 | News

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...

May 11, 2023 | News

Stay Connected